Zymergen Inc. (ZY) Announces Proposed 13.6M Share IPO Between $28-$31/Sh

Zymergen Inc. (NASDAQ: ZY), one of the world’s foremost biofacturing companies, today announced that it has launched the roadshow for the initial public offering (“IPO”) of 13,600,000 shares of its common stock. The initial offering price is expected to be between $28 and $31 per share. The underwriters of the offering will also have a 30-day option to purchase from Zymergen up to an additional 2,040,000 shares of its common stock. Zymergen has applied to list its common stock on the Nasdaq Global Select Market under the symbol "ZY."

J.P. Morgan and Goldman Sachs & Co. LLC are acting as lead book-running managers for the offering. BofA Securities, Cowen and UBS Investment Bank are acting as book-running managers. Lazard is acting as co-manager.

The offering will be made only by means of a prospectus.

You May Also Be Interested In

• Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
• Lithium Americas Corp (LAC) Announces Proposed 55M Share Offering
• Biohaven Pharma (BHVN) Prices 5.6M Share Offering at $41/sh